By Tarun Sai Lomte A groundbreaking clinical trial shows how a personalized cancer vaccine primes the immune system to target kidney cancer, preventing recurrence and offering new hope for patients ...
Jack Craig took the reins as president and chief executive officer of CNL last April, assuming that role from Joe McBrearty, who had helmed the company for four years prior to that.